Dose, Adherence, and the Long Middle of Phototherapy
About this video
Three months into phototherapy, a patient may have little pigment to show for it. Before deciding that light isn’t working, there are other questions to ask. How many sessions have they actually completed? Has the dose climbed steadily, or did a 2-week trip send it back toward the start? Are they still using their topicals, and as often as prescribed?
In this conversation, Gina Mangin, PA-C, and Nada M. Elbuluk, MD, discuss the decisions that shape phototherapy for vitiligo, from choosing between targeted treatment and whole-body narrowband UVB to finding a schedule a patient can sustain. Both generally prefer to start patients in the office to confirm a response before moving to a home unit. Home treatment removes the burden of frequent visits, but it shifts more of the monitoring to the patient. That is why Dr Elbuluk asks for a log of each session, its duration, and any side effects.
They also describe how they adjust dosing when redness lingers or a burn occurs, and why escalation has to be tailored to the individual. Once pigment has returned, there is no established protocol for what comes next. Dr Elbuluk tapers patients off and gives them a break from an arduous routine, asking them to call right away if new spots appear. Mangin keeps many on weekly light, with weekend topicals for the areas that matter most to them. Both start from the same premise: the color has come back, but the disease has not gone away.